Related Experiment Video

Updated: Oct 4, 2025

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

8.7K

Improved Hematologic Outcomes in HIV1-Exposed Infants Receiving Nevirapine Compared With Zidovudine for Postnatal

Catherine Dollfus1, Jérome Le Chenadec2, Laurent Mandelbrot3,4

  • 1From the Service d'Hématologie et Oncologie Pédiatrique, Hôpital d'Enfants Armand Trousseau, APHP Sorbonne Université, Paris, France.

The Pediatric Infectious Disease Journal
|February 9, 2022
PubMed

Insights

Nevirapine (NVP) showed fewer anemia cases than zidovudine in HIV-exposed infants. NVP is preferred for low-risk infants to prevent mother-to-child HIV transmission.

Area of Science:

  • Pediatric Infectious Diseases
  • HIV/AIDS Research
  • Neonatal Health

Background:

  • HIV-1 transmission can occur during pregnancy, labor, or postpartum.
  • Postnatal antiretroviral prophylaxis is crucial for preventing mother-to-child HIV transmission.
  • Evaluating the safety and efficacy of different prophylactic regimens in infants is essential.

Purpose of the Study:

  • To compare the outcomes of nevirapine (NVP) versus zidovudine for postnatal prophylaxis in HIV-1 exposed infants.
  • To assess the incidence of anemia in infants receiving NVP compared to zidovudine.

Main Methods:

  • Prospective cohort study of 830 HIV-1 exposed infants.
  • Comparison of infants receiving nevirapine (NVP) or zidovudine for postnatal prophylaxis.
  • Assessment of anemia grade ≥2 at 1 month of age.

Main Results:

  • Anemia grade ≥2 was significantly less frequent in infants receiving NVP (2.9%) compared to zidovudine (8.0%; P = 0.01).
  • This finding suggests a potential safety advantage for NVP regarding anemia.

Conclusions:

  • Nevirapine (NVP) may be a preferred first-choice prophylactic agent for infants at low risk of HIV acquisition due to a lower incidence of anemia.
  • Further research may explore long-term outcomes and optimal prophylaxis strategies.

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.7K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.0K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.3K
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.8K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
8
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
21